>
Switch to:

Eidos Therapeutics Gross Margin %

: 0.00% (As of Sep. 2020)
View and export this data going back to 2018. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. Eidos Therapeutics's Gross Profit for the three months ended in Sep. 2020 was $0.13 Mil. Eidos Therapeutics's Revenue for the three months ended in Sep. 2020 was $0.13 Mil. Therefore, Eidos Therapeutics's Gross Margin % for the quarter that ended in Sep. 2020 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.



During the past 4 years, the highest Gross Margin % of Eidos Therapeutics was 90.63%. The lowest was 0.00%. And the median was 90.63%.


Eidos Therapeutics had a gross margin of N/A% for the quarter that ended in Sep. 2020 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Eidos Therapeutics was 0.00% per year.


Eidos Therapeutics Gross Margin % Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Eidos Therapeutics Annual Data
Dec16 Dec17 Dec18 Dec19
Gross Margin % 0.00 0.00 0.00 90.63

Eidos Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Gross Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.63 0.00 0.00 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Eidos Therapeutics Gross Margin % Distribution

* The bar in red indicates where Eidos Therapeutics's Gross Margin % falls into.



Eidos Therapeutics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Eidos Therapeutics's Gross Margin for the fiscal year that ended in Dec. 2019 is calculated as

Gross Margin % (A: Dec. 2019 )=Gross Profit (A: Dec. 2019 ) / Revenue (A: Dec. 2019 )
=24.2 / 26.691
=(Revenue - Cost of Goods Sold) / Revenue
=(26.691 - 2.5) / 26.691
=90.63 %

Eidos Therapeutics's Gross Margin for the quarter that ended in Sep. 2020 is calculated as


Gross Margin % (Q: Sep. 2020 )=Gross Profit (Q: Sep. 2020 ) / Revenue (Q: Sep. 2020 )
=0.1 / 0.127
=(Revenue - Cost of Goods Sold) / Revenue
=(0.127 - 0) / 0.127
=N/A %

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Eidos Therapeutics  (NAS:EIDX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Eidos Therapeutics had a gross margin of N/A% for the quarter that ended in Sep. 2020 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Eidos Therapeutics Gross Margin % Related Terms


Eidos Therapeutics Gross Margin % Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)